Amikacin liposome inhalation suspension for treatment-refractory lung disease caused by Mycobacterium avium complex (CONVERT) a prospective, open-label, randomized study
David E. Griffith, Gina Eagle, Rachel Thomson, Timothy R. Aksamit, Naoki Hasegawa, Kozo Morimoto, Doreen J. Addrizzo-Harris, Anne E. O'Donnell, Theodore K. Marras, Patrick A. Flume, Michael R. Loebinger, Lucy Morgan, Luigi R. Codecasa, Adam T. Hill, Stephen J. Ruoss, Jae Joon Yim, Felix C. Ringshausen, Stephen K. Field, Julie V. Philley, Richard J. Wallace
研究成果: Article › 査読
154
被引用数
(Scopus)